These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

370 related items for PubMed ID: 19502578

  • 1. Methylphenidate induction of complex visual hallucinations.
    Halevy A, Shuper A.
    J Child Neurol; 2009 Aug; 24(8):1005-7. PubMed ID: 19502578
    [Abstract] [Full Text] [Related]

  • 2. Methylphenidate-induced visual hallucinations.
    Porfirio MC, Giana G, Giovinazzo S, Curatolo P.
    Neuropediatrics; 2011 Feb; 42(1):30-1. PubMed ID: 21500140
    [Abstract] [Full Text] [Related]

  • 3. Acute dyskinesia on starting methylphenidate after risperidone withdrawal.
    Hollis CP, Thompson A.
    Pediatr Neurol; 2007 Oct; 37(4):287-8. PubMed ID: 17903675
    [Abstract] [Full Text] [Related]

  • 4. Risperidone-to-methylphenidate switch reaction in children: three cases.
    Sabuncuoglu O.
    J Psychopharmacol; 2007 Mar; 21(2):216-9. PubMed ID: 17329303
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and safety of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, double-blind, parallel group, dose-escalation study.
    Adler LA, Zimmerman B, Starr HL, Silber S, Palumbo J, Orman C, Spencer T.
    J Clin Psychopharmacol; 2009 Jun; 29(3):239-47. PubMed ID: 19440077
    [Abstract] [Full Text] [Related]

  • 6. Transdermal methylphenidate (Daytrana) for ADHD.
    Med Lett Drugs Ther; 2006 Jun 19; 48(1237):49-51. PubMed ID: 16785850
    [No Abstract] [Full Text] [Related]

  • 7. Cardiac arrest with pulseless electrical activity associated with methylphenidate in an adolescent with a normal baseline echocardiogram.
    Daly MW, Custer G, McLeay PD.
    Pharmacotherapy; 2008 Nov 19; 28(11):1408-12. PubMed ID: 18957001
    [Abstract] [Full Text] [Related]

  • 8. Long lasting complex nocturnal hallucinations during Osmotic Release Oral System (OROS) methylphenidate treatment in a 7-year old girl.
    Goetz M, Prihodova I, Hrdlicka M.
    Neuro Endocrinol Lett; 2011 Nov 19; 32(5):619-22. PubMed ID: 22167138
    [Abstract] [Full Text] [Related]

  • 9. Depressive symptoms as a side effect of the sustained release form of methylphenidate in a 7-year-old boy with attention-deficit hyperactivity disorder.
    Lakić A.
    Vojnosanit Pregl; 2012 Feb 19; 69(2):201-4. PubMed ID: 22500377
    [Abstract] [Full Text] [Related]

  • 10. Focalin XR for ADHD.
    Med Lett Drugs Ther; 2009 Mar 23; 51(1308):22-4. PubMed ID: 19305368
    [No Abstract] [Full Text] [Related]

  • 11. Long-term tolerability of the methylphenidate transdermal system in pediatric attention-deficit/hyperactivity disorder: a multicenter, prospective, 12-month, open-label, uncontrolled, phase III extension of four clinical trials.
    Findling RL, Wigal SB, Bukstein OG, Boellner SW, Abikoff HB, Turnbow JM, Civil R.
    Clin Ther; 2009 Aug 23; 31(8):1844-55. PubMed ID: 19808143
    [Abstract] [Full Text] [Related]

  • 12. Methylphenidate-associated enuresis in attention deficit hyperactivity disorder.
    Ghanizadeh A.
    J Pediatr Urol; 2008 Aug 23; 4(4):306-7. PubMed ID: 18644535
    [Abstract] [Full Text] [Related]

  • 13. Visual Hallucinations with Methylphenidate and Acetaminophen in Combination.
    Hergüner S, Özayhan HY.
    J Child Adolesc Psychopharmacol; 2015 Sep 23; 25(7):598-9. PubMed ID: 26222326
    [No Abstract] [Full Text] [Related]

  • 14. Pharmacological management of treatment-induced insomnia in ADHD.
    Kratochvil CJ, Lake M, Pliszka SR, Walkup JT.
    J Am Acad Child Adolesc Psychiatry; 2005 May 23; 44(5):499-501. PubMed ID: 15843773
    [No Abstract] [Full Text] [Related]

  • 15. Better efficacy for the osmotic release oral system methylphenidate among poor adherents to immediate-release methylphenidate in the three ADHD subtypes.
    Chou WJ, Chou MC, Tzang RF, Hsu YC, Gau SS, Chen SJ, Wu YY, Huang YF, Liang HY, Cheng H.
    Psychiatry Clin Neurosci; 2009 Apr 23; 63(2):167-75. PubMed ID: 19335386
    [Abstract] [Full Text] [Related]

  • 16. ADHD, methylphenidate and driving: does some legislation endanger public health?
    Verster JC, Cox DJ.
    J Psychopharmacol; 2008 May 23; 22(3):227-9. PubMed ID: 18541623
    [No Abstract] [Full Text] [Related]

  • 17. Cardiovascular effects of methylphenidate.
    Daniels SR.
    J Pediatr; 2009 Jul 23; 155(1):A3. PubMed ID: 19559283
    [No Abstract] [Full Text] [Related]

  • 18. [Graphomotor functions in children with attention deficit hyperactivity disorder (ADHD)].
    Stasik D, Tucha O, Tucha L, Walitza S, Lange KW.
    Psychiatr Pol; 2009 Jul 23; 43(2):183-92. PubMed ID: 19697788
    [Abstract] [Full Text] [Related]

  • 19. [Methylphenidate. A drug for attention deficit disorders to be used with precaution].
    Taéron C.
    Rev Infirm; 2009 Jun 23; (151):47-9. PubMed ID: 19579855
    [No Abstract] [Full Text] [Related]

  • 20. [Methylphenidate of retard forms in children and adolescents with ADHD - an overview].
    Pelz R, Banaschewski T, Becker K.
    Klin Padiatr; 2008 Jun 23; 220(2):93-100. PubMed ID: 18157763
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.